DK1025847T3 - Neovaskulariseringspromotorer og neovaskulariseringsforstarkere - Google Patents

Neovaskulariseringspromotorer og neovaskulariseringsforstarkere

Info

Publication number
DK1025847T3
DK1025847T3 DK98940584T DK98940584T DK1025847T3 DK 1025847 T3 DK1025847 T3 DK 1025847T3 DK 98940584 T DK98940584 T DK 98940584T DK 98940584 T DK98940584 T DK 98940584T DK 1025847 T3 DK1025847 T3 DK 1025847T3
Authority
DK
Denmark
Prior art keywords
neovascularization
angiogenesis
enhancers
promoters
acceptable salt
Prior art date
Application number
DK98940584T
Other languages
Danish (da)
English (en)
Inventor
Yasuhiro Egi
Hideaki Kido
Kazutaka Hayashi
Yoshiji Kubo
Norifumi Nakamura
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of DK1025847T3 publication Critical patent/DK1025847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK98940584T 1997-08-28 1998-08-26 Neovaskulariseringspromotorer og neovaskulariseringsforstarkere DK1025847T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23264497 1997-08-28

Publications (1)

Publication Number Publication Date
DK1025847T3 true DK1025847T3 (da) 2006-02-13

Family

ID=16942531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98940584T DK1025847T3 (da) 1997-08-28 1998-08-26 Neovaskulariseringspromotorer og neovaskulariseringsforstarkere

Country Status (13)

Country Link
US (1) US6284758B1 (de)
EP (1) EP1025847B1 (de)
JP (1) JP4352613B2 (de)
KR (1) KR100559192B1 (de)
CN (1) CN1142779C (de)
AT (1) ATE307584T1 (de)
AU (1) AU8886298A (de)
CA (1) CA2301852C (de)
DE (1) DE69832089T2 (de)
DK (1) DK1025847T3 (de)
ES (1) ES2247716T3 (de)
TW (1) TW490303B (de)
WO (1) WO1999011268A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100633869B1 (ko) * 1998-12-07 2006-10-16 닛산 가가쿠 고교 가부시키 가이샤 발기 부전 치료제
BRPI0417200A (pt) * 2003-12-26 2007-02-06 Nissan Chemical Ind Ltd agente antineutrofilia
RU2339381C2 (ru) * 2004-02-09 2008-11-27 Ниссан Кемикал Индастриз, Лтд. Ингибитор гиперплазии интимы сосудов
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
PL1909973T3 (pl) 2005-07-15 2019-01-31 Micell Technologies, Inc. Polimerowe powłoki zawierające proszek leku o kontrolowanej morfologii
US8852625B2 (en) 2006-04-26 2014-10-07 Micell Technologies, Inc. Coatings containing multiple drugs
CN102886326A (zh) 2006-10-23 2013-01-23 米歇尔技术公司 用于在涂覆过程中为基底充电的保持器
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
WO2008105260A1 (ja) * 2007-02-28 2008-09-04 Ltt Bio-Pharma Co., Ltd. 下肢切断手術の予後を改善する治療剤
EP2170418B1 (de) 2007-05-25 2016-03-16 Micell Technologies, Inc. Polymerfilme zur beschichtung von medizinprodukten
US8685432B2 (en) * 2008-03-25 2014-04-01 University Of Utah Research Foundation Controlled release tissue graft combination biomaterials
AU2009251504B2 (en) 2008-04-17 2013-09-05 Micell Technologies, Inc. Stents having bioabsorbable layers
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
EP2411083A4 (de) 2009-03-23 2013-11-13 Micell Technologies Inc Medizinische wirkstofffreisetzungsvorrichtung
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
EP2419058B1 (de) 2009-04-17 2018-02-28 Micell Technologies, Inc. Stents mit gesteuerter elution
EP2531140B1 (de) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133183A1 (en) 2010-04-20 2011-10-27 University Of Utah Research Foundation Phase separation sprayed scaffold
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
US10464100B2 (en) 2011-05-31 2019-11-05 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US9889235B2 (en) 2013-02-05 2018-02-13 University Of Utah Research Foundation Implantable devices for bone or joint defects
JP6330024B2 (ja) 2013-03-12 2018-05-23 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
CN105377318A (zh) 2013-05-15 2016-03-02 脉胜医疗技术公司 可生物吸收的生物医学植入物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0482208B1 (de) 1990-04-25 2000-07-19 Nissan Chemical Industries Ltd. Pyridazinonderivat
CA2063055A1 (en) * 1991-05-22 1992-11-23 Jacob Eyal Peptides having thrombospondin-like activity and their therapeutic use
JP3666042B2 (ja) * 1994-01-25 2005-06-29 日産化学工業株式会社 ピリダジノン誘導体
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives

Also Published As

Publication number Publication date
EP1025847B1 (de) 2005-10-26
JP4352613B2 (ja) 2009-10-28
DE69832089T2 (de) 2006-07-20
CA2301852A1 (en) 1999-03-11
DE69832089D1 (de) 2005-12-01
US6284758B1 (en) 2001-09-04
TW490303B (en) 2002-06-11
CN1142779C (zh) 2004-03-24
KR20010023331A (ko) 2001-03-26
WO1999011268A1 (fr) 1999-03-11
AU8886298A (en) 1999-03-22
CN1277553A (zh) 2000-12-20
ATE307584T1 (de) 2005-11-15
ES2247716T3 (es) 2006-03-01
KR100559192B1 (ko) 2006-03-13
CA2301852C (en) 2007-07-10
EP1025847A1 (de) 2000-08-09
EP1025847A4 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
DK1025847T3 (da) Neovaskulariseringspromotorer og neovaskulariseringsforstarkere
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
PA8561901A1 (es) Cis-imidazolinas
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
DK1300398T3 (da) Propan-1,3-dionderivat
DK1414828T3 (da) Antitumoranaloger
PT981330E (pt) Composicoes topicas
SE9903759D0 (sv) Pharmaceutically active compounds
DE69309435T2 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
EP1176141A4 (de) HETEROCYCLISCHE VERBINDUNGEN DIE EINEN DEN NIKOTIN-ACETYLCHOLIN -g(a)4-g(b)2-REZEPTOR AKTIVIERENDEN EFFEKT BESITZEN
ATE438626T1 (de) 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivate und deren salze
ATE253360T1 (de) Acridine derivate zur verbesserung der oralen bioverfügbarkeit von taxol
ATE328888T1 (de) Radicicol und monocillin und ihre analogen und ihre anwendungen
BR0105563A (pt) Derivados e análogos de galantamina
BR0013292A (pt) Derivados de benzenamina como anti-coagulantes
DE60330391D1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
DE69925250D1 (de) Aktivatoren der kalium-kanäle
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme
DK1307454T3 (da) Variolin b-derivater
EP1464636A4 (de) Neue substanz mit antitumorwirkung/entzündungshemmender wirkung
ATE319452T1 (de) Arzneimittel gegen essstörungen
EP1210948B8 (de) Peptid zur behandlung von nervenerkrankungen
ATE282611T1 (de) Stolonoxide